CLINICAL_TRIALS
withdrawal
· 2012-04-13
Clinical Trial Update: Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection [Phase 2, Phase 3]
Summary
Clinical trial investigating the pharmacokinetics of the mefloquine-artesunate combination in pregnant women with uncomplicated Plasmodium falciparum malaria ha…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centers for Disease Control and Prevention | Conditions: Malaria, Pregnancy | Phase 2, Phase 3 | Status: WITHDRAWN